Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Charter Medical, a Lydall company, has received 510(k) clearance for Cell-Freeze cryogenic storage containers designed for peripherally derived stem cell applications.
Subscribe to our email newsletter
Cell-Freeze is used for cryogenic temperature applications as low as -196°C for storage, preservation and transfer. Cell-Freeze containers have a uniquely designed proprietary membrane port with attached cap to minimize exposure of the product, the company said.
Cell-Freeze containers have pre-attached labels making it easy to include manual information or adhere computer generated labels. They are available in a range of configurations to fit a variety of freezing systems.
Peter Ferris, president of Charter Medical, said: “We are excited to introduce Cell-Freeze cryogenic storage containers for peripheral blood stem cells. This innovative new product leverages Charter Medical’s years of expertise in blood transfusion and cell therapy applications.”